IDXG

Interpace Biosciences, Inc. Common Stock
IDXG

Delisted

IDXG was delisted on the 24th of February, 2021.

16 hedge funds and large institutions have $704K invested in Interpace Biosciences, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
2
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
BlackRock
1
BlackRock
New York
$212K +$212K +8,039 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$122K +$87.9K +3,355 +257%
Morgan Stanley
3
Morgan Stanley
New York
$104K +$104K +3,942 New
AS
4
Arxis Securities
New York
$96K +$96K +3,640 New
AA
5
Ancora Advisors
Ohio
$39K
JPMorgan Chase & Co
6
JPMorgan Chase & Co
New York
$37K +$37K +1,415 New
RJA
7
Raymond James & Associates
Florida
$34K +$34K +1,280 New
TSS
8
Two Sigma Securities
New York
$31K +$31K +1,195 New
GT
9
Glenmede Trust
Pennsylvania
$20K
TDC
10
Thompson Davis & Co
Virginia
$5K +$5K +200 New
UBS Group
11
UBS Group
Switzerland
$3K -$1.19K -48 -28%
Deutsche Bank
12
Deutsche Bank
Germany
$1K +$600 +24 +150%
Renaissance Technologies
13
Renaissance Technologies
New York
-$292K -6,642 Closed
VKH
14
Virtu KCG Holdings
New York
-$108K -4,045 Closed
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
-$64K -1,448 Closed